1-3 of 3
enzalutamide
Close
Sort by
Journal Articles

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Pável E Olivera, MD, César A Velasquez, MD, Desirée Campoy, MD, Gonzalo Artaza, MD, Tania Canals, MD, Katia Flores, MD, Silvia Ruiz, MD, Alessandra Comai, MD, Erik A Johansson, MD, Gabriela S Ene, MD PhD, Gabriela Bastidas, MD, Maricel Subira, MD PhD, Jorge Sierra, MD, Ramón Salinas, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3661.
https://doi.org/10.1182/blood-2019-128300
Published: 2019
Journal Articles

Androgen Receptor Targeting with Enzalutamide for Mantle Cell Lymphoma: Safety and Efficacy

Victor A. Chow, MD, Paul S. Martin, MD, Stephen D. Smith, MD, Brian G. Till, MD, Solomon A. Graf, MD, Kerstin L. Edlefsen, MD, Lindsay M. Hannan, MD MSPH, Elahe A. Mostaghel, MD PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5254.
https://doi.org/10.1182/blood-2019-125462
Published: 2019
Journal Articles

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Paul S Martin, MD, Elahe Mostaghel, MD PhD, Stephen Mongovin, Shani L. Frayo, Ailin Zhang, Kerstin Lara Edlefsen, MD, Oliver W Press, MD PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2016) 128 (22): 3014.
https://doi.org/10.1182/blood.V128.22.3014.3014
Published: 2016